How much is the Compounding Pharmacy market?

The compounding pharmacy market size is estimated to grow at $$ 1.74 bn in 2024. Read More

What is the growth rate of the Compounding Pharmacy market?

The growth rate of the compounding pharmacy year-over-year is 2.2%. Read More

Which region held the largest market share in the Compounding Pharmacy market?

North America is the region to held the largest market share with 40% growth. Read More

Who are the key players in the Compounding Pharmacy market?

ACPHARM QUEENSLAND Pty Ltd. (Australia), Advance Pharmacy (United States), B.Braun SE (Germany), Doughertys Pharmacy (United States), Fagron NV (Netherlands), Fresenius Kabi AG (Germany), Institutional .... Read More

Which Segment has the largest market share in the Compounding Pharmacy market?

Product is the segment that has the largest market share in the market. Read More

Compounding Pharmacy Market Analysis, Size, and Forecast 2025-2029: North America (US and Canada), Europe (France, Germany, and UK), APAC (China, India, Japan, and South Korea), and Rest of World (ROW)

Published: Jan 2025
Pages: 199
SKU: IRTNTR74609

Enjoy complimentary customisation on priority with our Enterprise License!

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Therapeutic Area
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation

2.3 Factors of disruption
- Overview on factors of disruption

2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market

3.2 Market characteristics
- Market characteristics analysis

3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition

4.2 Market segment analysis
- Market segments

4.3 Market size 2024

4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Compounding Pharmacy Market 2019 - 2023
- Historic Market Size - Data Table on Global Compounding Pharmacy Market 2019 - 2023 ($ million)

5.2 Product segment analysis 2019 - 2023
- Historic Market Size - Product Segment 2019 - 2023 ($ million)

5.3 Therapeutic Area segment analysis 2019 - 2023
- Historic Market Size - Therapeutic Area Segment 2019 - 2023 ($ million)

5.4 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)

5.5 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

6.1 The AI impact on Global Compounding Pharmacy Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029

7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029

7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029

7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029

7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029

7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029

7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Product

8.1 Market segments
- Chart on Product - Market share (2024-2029) (%)
- Data Table on Product - Market share (2024-2029) (%)
- Chart on Otic preparations - Market size and forecast (2024-2029) ($ million)
- Data Table on Otic preparations - Market size and forecast (2024-2029) ($ million)
- Chart on Otic preparations - Year-over-year growth (2024-2029) (%)
- Data Table on Otic preparations - Year-over-year growth (2024-2029) (%)

8.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
- Chart on Sterile Compounds - Market size and forecast (2024-2029) ($ million)
- Data Table on Sterile Compounds - Market size and forecast (2024-2029) ($ million)
- Chart on Sterile Compounds - Year-over-year growth (2024-2029) (%)
- Data Table on Sterile Compounds - Year-over-year growth (2024-2029) (%)

8.3 Topical medications - Market size and forecast (2024-2029)
- Chart on Topical medications - Market size and forecast (2024-2029) ($ million)
- Data Table on Topical medications - Market size and forecast (2024-2029) ($ million)
- Chart on Topical medications - Year-over-year growth (2024-2029) (%)
- Data Table on Topical medications - Year-over-year growth (2024-2029) (%)
- Chart on Others - Market size and forecast (2024-2029) ($ million)
- Data Table on Others - Market size and forecast (2024-2029) ($ million)
- Chart on Others - Year-over-year growth (2024-2029) (%)
- Data Table on Others - Year-over-year growth (2024-2029) (%)

8.4 Oral medications - Market size and forecast (2024-2029)
- Chart on Oral medications - Market size and forecast (2024-2029) ($ million)
- Data Table on Oral medications - Market size and forecast (2024-2029) ($ million)
- Chart on Oral medications - Year-over-year growth (2024-2029) (%)
- Data Table on Oral medications - Year-over-year growth (2024-2029) (%)
- Market opportunity by Product ($ million)
- Data Table on Market opportunity by Product ($ million)

8.5 Parenteral medications - Market size and forecast (2024-2029)
- Chart on Parenteral medications - Market size and forecast (2024-2029) ($ million)
- Data Table on Parenteral medications - Market size and forecast (2024-2029) ($ million)
- Chart on Parenteral medications - Year-over-year growth (2024-2029) (%)
- Data Table on Parenteral medications - Year-over-year growth (2024-2029) (%)

8.6 Suppositories - Market size and forecast (2024-2029)
- Chart on Suppositories - Market size and forecast (2024-2029) ($ million)
- Data Table on Suppositories - Market size and forecast (2024-2029) ($ million)
- Chart on Suppositories - Year-over-year growth (2024-2029) (%)
- Data Table on Suppositories - Year-over-year growth (2024-2029) (%)

8.7 Mouthwashes - Market size and forecast (2024-2029)
- Chart on Mouthwashes - Market size and forecast (2024-2029) ($ million)
- Data Table on Mouthwashes - Market size and forecast (2024-2029) ($ million)
- Chart on Mouthwashes - Year-over-year growth (2024-2029) (%)
- Data Table on Mouthwashes - Year-over-year growth (2024-2029) (%)

8.8 Ophthalmic preparations - Market size and forecast (2024-2029)
- Chart on Ophthalmic preparations - Market size and forecast (2024-2029) ($ million)
- Data Table on Ophthalmic preparations - Market size and forecast (2024-2029) ($ million)
- Chart on Ophthalmic preparations - Year-over-year growth (2024-2029) (%)
- Data Table on Ophthalmic preparations - Year-over-year growth (2024-2029) (%)

8.9 Nasal preparations - Market size and forecast (2024-2029)
- Chart on Nasal preparations - Market size and forecast (2024-2029) ($ million)
- Data Table on Nasal preparations - Market size and forecast (2024-2029) ($ million)
- Chart on Nasal preparations - Year-over-year growth (2024-2029) (%)
- Data Table on Nasal preparations - Year-over-year growth (2024-2029) (%)

9 Market Segmentation by Therapeutic Area

9.1 Market segments
- Chart on Therapeutic Area - Market share (2024-2029) (%)
- Data Table on Therapeutic Area - Market share (2024-2029) (%)
- Chart on compounded oncology drug - Market size and forecast (2024-2029) ($ million)
- Data Table on compounded oncology drug - Market size and forecast (2024-2029) ($ million)
- Chart on compounded oncology drug - Year-over-year growth (2024-2029) (%)
- Data Table on compounded oncology drug - Year-over-year growth (2024-2029) (%)

9.2 Comparison by Therapeutic Area
- Chart on Comparison by Therapeutic Area
- Data Table on Comparison by Therapeutic Area
- Chart on Pelvic Pain - Market size and forecast (2024-2029) ($ million)
- Data Table on Pelvic Pain - Market size and forecast (2024-2029) ($ million)
- Chart on Pelvic Pain - Year-over-year growth (2024-2029) (%)
- Data Table on Pelvic Pain - Year-over-year growth (2024-2029) (%)

9.3 Pain management - Market size and forecast (2024-2029)
- Chart on Pain management - Market size and forecast (2024-2029) ($ million)
- Data Table on Pain management - Market size and forecast (2024-2029) ($ million)
- Chart on Pain management - Year-over-year growth (2024-2029) (%)
- Data Table on Pain management - Year-over-year growth (2024-2029) (%)
- Chart on Gastrointestinal Conditions - Market size and forecast (2024-2029) ($ million)
- Data Table on Gastrointestinal Conditions - Market size and forecast (2024-2029) ($ million)
- Chart on Gastrointestinal Conditions - Year-over-year growth (2024-2029) (%)
- Data Table on Gastrointestinal Conditions - Year-over-year growth (2024-2029) (%)

9.4 Hormone replacement - Market size and forecast (2024-2029)
- Chart on Hormone replacement - Market size and forecast (2024-2029) ($ million)
- Data Table on Hormone replacement - Market size and forecast (2024-2029) ($ million)
- Chart on Hormone replacement - Year-over-year growth (2024-2029) (%)
- Data Table on Hormone replacement - Year-over-year growth (2024-2029) (%)
- Chart on Allergy Treatments - Market size and forecast (2024-2029) ($ million)
- Data Table on Allergy Treatments - Market size and forecast (2024-2029) ($ million)
- Chart on Allergy Treatments - Year-over-year growth (2024-2029) (%)
- Data Table on Allergy Treatments - Year-over-year growth (2024-2029) (%)

9.5 Dermatological applications - Market size and forecast (2024-2029)
- Chart on Dermatological applications - Market size and forecast (2024-2029) ($ million)
- Data Table on Dermatological applications - Market size and forecast (2024-2029) ($ million)
- Chart on Dermatological applications - Year-over-year growth (2024-2029) (%)
- Data Table on Dermatological applications - Year-over-year growth (2024-2029) (%)
- Market opportunity by Therapeutic Area ($ million)
- Data Table on Market opportunity by Therapeutic Area ($ million)

9.6 Nutritional supplements - Market size and forecast (2024-2029)
- Chart on Nutritional supplements - Market size and forecast (2024-2029) ($ million)
- Data Table on Nutritional supplements - Market size and forecast (2024-2029) ($ million)
- Chart on Nutritional supplements - Year-over-year growth (2024-2029) (%)
- Data Table on Nutritional supplements - Year-over-year growth (2024-2029) (%)

9.7 Specialty drugs - Market size and forecast (2024-2029)
- Chart on Specialty drugs - Market size and forecast (2024-2029) ($ million)
- Data Table on Specialty drugs - Market size and forecast (2024-2029) ($ million)
- Chart on Specialty drugs - Year-over-year growth (2024-2029) (%)
- Data Table on Specialty drugs - Year-over-year growth (2024-2029) (%)

9.8 Pediatric applications - Market size and forecast (2024-2029)
- Chart on Pediatric applications - Market size and forecast (2024-2029) ($ million)
- Data Table on Pediatric applications - Market size and forecast (2024-2029) ($ million)
- Chart on Pediatric applications - Year-over-year growth (2024-2029) (%)
- Data Table on Pediatric applications - Year-over-year growth (2024-2029) (%)

9.9 Veterinary applications - Market size and forecast (2024-2029)
- Chart on Veterinary applications - Market size and forecast (2024-2029) ($ million)
- Data Table on Veterinary applications - Market size and forecast (2024-2029) ($ million)
- Chart on Veterinary applications - Year-over-year growth (2024-2029) (%)
- Data Table on Veterinary applications - Year-over-year growth (2024-2029) (%)

10 Customer Landscape

10.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

11 Geographic Landscape

11.1 Geographic segmentation
- Chart on Market share by geography 2024-2029 (%)
- Data Table on Market share by geography 2024-2029 (%)

11.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison

11.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)

11.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)

11.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)

11.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)

11.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)

11.8 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)

11.9 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)

11.10 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)

11.11 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)

11.12 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)

11.13 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)

11.14 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)

11.15 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ million)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)

11.16 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ million)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)

11.17 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)

11.18 BrazilUAE - Market size and forecast (2024-2029)
- Chart on BrazilUAE - Market size and forecast (2024-2029) ($ million)
- Data Table on BrazilUAE - Market size and forecast (2024-2029) ($ million)
- Chart on BrazilUAE - Year-over-year growth (2024-2029) (%)
- Data Table on BrazilUAE - Year-over-year growth (2024-2029) (%)

12 Drivers, Challenges, and Opportunity/Restraints

12.1 Market drivers

12.2 Market challenges

12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

12.4 Market opportunities/restraints

13 Competitive Landscape

13.1 Overview

13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation

13.3 Landscape disruption
- Overview on factors of disruption

13.4 Industry risks
- Impact of key risks on business

14 Competitive Analysis

14.1 Companies profiled
- Companies covered

14.2 Market positioning of companies
- Matrix on companies position and classification

14.3 ACPHARM QUEENSLAND Pty Ltd. (Australia)
- ACPHARM QUEENSLAND Pty Ltd. (Australia) - Overview
- ACPHARM QUEENSLAND Pty Ltd. (Australia) - Product / Service
- ACPHARM QUEENSLAND Pty Ltd. (Australia) - Key offerings

14.4 Advance Pharmacy (United States)
- Advance Pharmacy (United States) - Overview
- Advance Pharmacy (United States) - Product / Service
- Advance Pharmacy (United States) - Key offerings

14.5 B.Braun SE (Germany)
- B.Braun SE (Germany) - Overview
- B.Braun SE (Germany) - Product / Service
- B.Braun SE (Germany) - Key offerings

14.6 Doughertys Pharmacy (United States)
- Doughertys Pharmacy (United States) - Overview
- Doughertys Pharmacy (United States) - Product / Service
- Doughertys Pharmacy (United States) - Key offerings

14.7 Fagron NV (Netherlands)
- Fagron NV (Netherlands) - Overview
- Fagron NV (Netherlands) - Product / Service
- Fagron NV (Netherlands) - Key offerings

14.8 Fresenius Kabi AG (Germany)
- Fresenius Kabi AG (Germany) - Overview
- Fresenius Kabi AG (Germany) - Product / Service
- Fresenius Kabi AG (Germany) - Key offerings

14.9 Institutional Pharmacy Solutions (United States)
- Institutional Pharmacy Solutions (United States) - Overview
- Institutional Pharmacy Solutions (United States) - Product / Service
- Institutional Pharmacy Solutions (United States) - Key offerings

14.10 ITC Compounding Pharmacy (United States)
- ITC Compounding Pharmacy (United States) - Overview
- ITC Compounding Pharmacy (United States) - Product / Service
- ITC Compounding Pharmacy (United States) - Key offerings

14.11 Lee Silsby Compounding Pharmacy (United States)
- Lee Silsby Compounding Pharmacy (United States) - Overview
- Lee Silsby Compounding Pharmacy (United States) - Product / Service
- Lee Silsby Compounding Pharmacy (United States) - Key offerings

14.12 McGuff Co. Inc. (United States)
- McGuff Co. Inc. (United States) - Overview
- McGuff Co. Inc. (United States) - Product / Service
- McGuff Co. Inc. (United States) - Key offerings

14.13 Nephron Pharmaceuticals Corp. (United States)
- Nephron Pharmaceuticals Corp. (United States) - Overview
- Nephron Pharmaceuticals Corp. (United States) - Product / Service
- Nephron Pharmaceuticals Corp. (United States) - Key offerings

14.14 Olympia Pharmacy (United States)
- Olympia Pharmacy (United States) - Overview
- Olympia Pharmacy (United States) - Product / Service
- Olympia Pharmacy (United States) - Key offerings

14.15 PenCol Specialty Pharmacy (United States)
- PenCol Specialty Pharmacy (United States) - Overview
- PenCol Specialty Pharmacy (United States) - Product / Service
- PenCol Specialty Pharmacy (United States) - Key offerings

14.16 QuVa Pharma Inc. (United States)
- QuVa Pharma Inc. (United States) - Overview
- QuVa Pharma Inc. (United States) - Product / Service
- QuVa Pharma Inc. (United States) - Key offerings

14.17 Rx3 Compounding Pharmacy (United States)
- Rx3 Compounding Pharmacy (United States) - Overview
- Rx3 Compounding Pharmacy (United States) - Product / Service
- Rx3 Compounding Pharmacy (United States) - Key offerings

14.18 Triangle Compounding Pharmacy (United States)
- Triangle Compounding Pharmacy (United States) - Overview
- Triangle Compounding Pharmacy (United States) - Product / Service
- Triangle Compounding Pharmacy (United States) - Key offerings

14.19 Valor Compounding Pharmacy (United States)
- Valor Compounding Pharmacy (United States) - Overview
- Valor Compounding Pharmacy (United States) - Product / Service
- Valor Compounding Pharmacy (United States) - Key offerings

14.20 Village Compounding Pharmacy (United States)
- Village Compounding Pharmacy (United States) - Overview
- Village Compounding Pharmacy (United States) - Product / Service
- Village Compounding Pharmacy (United States) - Key offerings

14.21 Wedgewood Village Pharmacy LLC (United States)
- Wedgewood Village Pharmacy LLC (United States) - Overview
- Wedgewood Village Pharmacy LLC (United States) - Product / Service
- Wedgewood Village Pharmacy LLC (United States) - Key offerings

14.22 ACPHARM QUEENSLAND Pty Ltd.
- ACPHARM QUEENSLAND Pty Ltd. - Overview
- ACPHARM QUEENSLAND Pty Ltd. - Product / Service
- ACPHARM QUEENSLAND Pty Ltd. - Key offerings

14.23 Advance Pharmacy
- Advance Pharmacy - Overview
- Advance Pharmacy - Product / Service
- Advance Pharmacy - Key offerings

14.24 B.Braun SE
- B.Braun SE - Overview
- B.Braun SE - Product / Service
- B.Braun SE - Key offerings

14.25 Doughertys Pharmacy
- Doughertys Pharmacy - Overview
- Doughertys Pharmacy - Product / Service
- Doughertys Pharmacy - Key offerings

14.26 Fagron NV
- Fagron NV - Overview
- Fagron NV - Product / Service
- Fagron NV - Key offerings

14.27 Fresenius Kabi AG
- Fresenius Kabi AG - Overview
- Fresenius Kabi AG - Product / Service
- Fresenius Kabi AG - Key offerings

14.28 Institutional Pharmacy Solutions
- Institutional Pharmacy Solutions - Overview
- Institutional Pharmacy Solutions - Product / Service
- Institutional Pharmacy Solutions - Key offerings

14.29 ITC Compounding Pharmacy
- ITC Compounding Pharmacy - Overview
- ITC Compounding Pharmacy - Product / Service
- ITC Compounding Pharmacy - Key offerings

14.30 Lee Silsby Compounding Pharmacy
- Lee Silsby Compounding Pharmacy - Overview
- Lee Silsby Compounding Pharmacy - Product / Service
- Lee Silsby Compounding Pharmacy - Key offerings

14.31 McGuff Co. Inc.
- McGuff Co. Inc. - Overview
- McGuff Co. Inc. - Product / Service
- McGuff Co. Inc. - Key offerings

14.32 Nephron Pharmaceuticals Corp.
- Nephron Pharmaceuticals Corp. - Overview
- Nephron Pharmaceuticals Corp. - Product / Service
- Nephron Pharmaceuticals Corp. - Key offerings

14.33 Olympia Pharmacy
- Olympia Pharmacy - Overview
- Olympia Pharmacy - Product / Service
- Olympia Pharmacy - Key offerings

14.34 PenCol Specialty Pharmacy
- PenCol Specialty Pharmacy - Overview
- PenCol Specialty Pharmacy - Product / Service
- PenCol Specialty Pharmacy - Key offerings

14.35 QuVa Pharma Inc.
- QuVa Pharma Inc. - Overview
- QuVa Pharma Inc. - Product / Service
- QuVa Pharma Inc. - Key offerings

14.36 Rx3 Compounding Pharmacy
- Rx3 Compounding Pharmacy - Overview
- Rx3 Compounding Pharmacy - Product / Service
- Rx3 Compounding Pharmacy - Key offerings

14.37 Triangle Compounding Pharmacy
- Triangle Compounding Pharmacy - Overview
- Triangle Compounding Pharmacy - Product / Service
- Triangle Compounding Pharmacy - Key offerings

14.38 Valor Compounding Pharmacy
- Valor Compounding Pharmacy - Overview
- Valor Compounding Pharmacy - Product / Service
- Valor Compounding Pharmacy - Key offerings

14.39 Village Compounding Pharmacy
- Village Compounding Pharmacy - Overview
- Village Compounding Pharmacy - Product / Service
- Village Compounding Pharmacy - Key offerings

14.40 Wedgewood Village Pharmacy LLC
- Wedgewood Village Pharmacy LLC - Overview
- Wedgewood Village Pharmacy LLC - Product / Service
- Wedgewood Village Pharmacy LLC - Key offerings

15 Appendix

15.1 Scope of the report

15.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist

15.3 Currency conversion rates for US$
- Currency conversion rates for US$

15.4 Research methodology
- Research methodology

15.5 Data procurement
- Information sources

15.6 Data validation
- Data validation

15.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing

15.8 Data synthesis
- Data synthesis

15.9 360 degree market analysis
- 360 degree market analysis

15.10 List of abbreviations
- List of abbreviations

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES